Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Treatment of hepatitis C virus genotype 4 in the DAA era.

Di Biagio A, Taramasso L, Cenderello G.

Virol J. 2018 Nov 22;15(1):180. doi: 10.1186/s12985-018-1094-4. Review.

2.

Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV.

Filaci G, Fenoglio D, Taramasso L, Indiveri F, Di Biagio A.

Front Immunol. 2018 Oct 23;9:2447. doi: 10.3389/fimmu.2018.02447. eCollection 2018.

3.

Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature.

Mirabella M, Taramasso L, Nicolini LA, Russo R, Viscoli C, Di Biagio A.

Clin Nephrol Case Stud. 2018 Oct 26;6:31-35. doi: 10.5414/CNCS109221. eCollection 2018.

4.

Ibalizumab and Fostemsavir in the Management of Heavily Pre-Treated HIV-infected Patients.

Riccardi N, Berruti M, Del Puente F, Taramasso L, Di Biagio A.

Recent Pat Antiinfect Drug Discov. 2018 Oct 31. doi: 10.2174/1574891X13666181031120019. [Epub ahead of print]

PMID:
30378502
5.

HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation.

Cenderello G, Taramasso L, Marra D, Orcamo P, Pasa A, Di Biagio A.

Expert Rev Pharmacoecon Outcomes Res. 2018 Oct 15:1-5. doi: 10.1080/14737167.2019.1537124. [Epub ahead of print]

PMID:
30321071
6.

How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy.

Taramasso L, Demma F, Bitonti R, Ferrazin A, Giannini B, Giacomini M, Beltramini S, Sasso E, Viscoli C, Di Biagio A.

BMC Health Serv Res. 2018 Sep 6;18(1):691. doi: 10.1186/s12913-018-3507-x.

7.

Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: results from a large observational cohort study (SCOLTA).

Taramasso L, Tatarelli P, Ricci E, Madeddu G, Menzaghi B, Squillace N, De Socio GV, Martinelli C, Gulminetti R, Maggi P, Orofino G, Vichi F, Di Biagio A, Bonfanti P; CISAI Study Group.

BMC Infect Dis. 2018 Jul 31;18(1):357. doi: 10.1186/s12879-018-3268-5.

8.

First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.

Taramasso L, Di Biagio A, Maggiolo F, Tavelli A, Lo Caputo S, Bonora S, Zaccarelli M, Caramello P, Costantini A, Viscoli C, d'Arminio Monforte A, Cozzi-Lepri A; Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group.

HIV Med. 2018 May 30. doi: 10.1111/hiv.12628. [Epub ahead of print]

PMID:
29846042
9.

Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment.

Taramasso L, Montanari L, Di Biagio A.

AIDS. 2018 Jun 1;32(9):1202-1203. doi: 10.1097/QAD.0000000000001804. No abstract available.

PMID:
29746321
10.

Hypertensive Versus HIV-infected Patients: Who Has the Greatest Target Organ Damage? Comparison of Carotid Plaque Prevalence, Intima Media Thickness and Renal Resistive Index in the Two Groups of Patients.

Taramasso L, Mirabella M, Cappadona F, Bonino B, Riccardi N, Cenderello G, De Socio GV, Viscoli C, Viazzi F, Di Biagio A.

Curr Hypertens Rev. 2018;14(1):48-55. doi: 10.2174/1573402114666180307145051.

PMID:
29521243
11.

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.

Taramasso L, Di Biagio A, Bovis F, Nicolini LA, Antinori A, Milazzo L, Sollima S, Gubertini G, Niero F, Saracino A, Bruno R, Borghi V, Montagnani F, Cattelan A, Hasson H, Taliani G, D'Arminio Monforte A, Mastroianni C, Di Perri G, Bigoni S, Puoti M, Spinetti A, Gori A, Boffa N, Cacopardo B, Giacometti A, Parruti G, Vullo V, Chirianni A, Teti E, Pasquazzi C, Segala D, Andreoni M.

PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.

12.

Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing.

Riccardi N, Giannini B, Borghesi ML, Taramasso L, Cattaneo E, Cenderello G, Toscanini F, Giacomini M, Pontali E, Cassola G, Viscoli C, Di Biagio A.

ERJ Open Res. 2018 Feb 2;4(1). pii: 00108-2017. doi: 10.1183/23120541.00108-2017. eCollection 2018 Jan.

13.

Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience.

Vitiello P, Taramasso L, Ricci E, Maggi P, Martinelli C, Gabrielli C, Vittorio De Socio G, Di Cristo V, Rusconi S, Falasca K, Menzaghi B, Tebini A, Di Biagio A; CISAI Study Group.

J Women Aging. 2018 Jan 25:1-13. doi: 10.1080/08952841.2018.1428100. [Epub ahead of print]

PMID:
29369016
14.

Weight Gain: A Possible Side Effect of All Antiretrovirals.

Taramasso L, Ricci E, Menzaghi B, Orofino G, Passerini S, Madeddu G, Martinelli CV, De Socio GV, Squillace N, Rusconi S, Bonfanti P, Di Biagio A; CISAI Study Group .

Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239. doi: 10.1093/ofid/ofx239. eCollection 2017 Fall.

15.

Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis?

Taramasso L, Riccardi N, Del Puente F, Bruzzone B, Ripamonti D, D'Ambrosio B, Viscoli C, Di Biagio A.

AIDS Res Hum Retroviruses. 2018 Feb;34(2):168-170. doi: 10.1089/AID.2017.0112. Epub 2018 Jan 18.

PMID:
29166777
16.

CD8+CD28-CD127loCD39+ regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?

Fenoglio D, Dentone C, Signori A, Di Biagio A, Parodi A, Kalli F, Nasi G, Curto M, Cenderello G, De Leo P, Bartolacci V, Orofino G, Nicolini LA, Taramasso L, Fiorillo E, Orrù V, Traverso P, Bruzzone B, Ivaldi F, Mantia E, Guerra M, Negrini S, Giacomini M, Bhagani S, Filaci G.

J Allergy Clin Immunol. 2018 Jun;141(6):2220-2233.e4. doi: 10.1016/j.jaci.2017.08.021. Epub 2017 Nov 2.

17.

Role of Raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents.

Taramasso L, Cenderello G, Riccardi N, Tunesi S, Di Biagio A.

New Microbiol. 2017 Oct;40(4):227-233. Epub 2017 Oct 10. Review.

18.

Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells.

Marras F, Casabianca A, Bozzano F, Ascierto ML, Orlandi C, Di Biagio A, Pontali E, Dentone C, Orofino G, Nicolini L, Taramasso L, Magnani M, Marincola FM, Wang E, Moretta L, De Maria A.

J Virol. 2017 Nov 14;91(23). pii: e00647-17. doi: 10.1128/JVI.00647-17. Print 2017 Dec 1.

19.

Bedaquiline: A New Hope for Shorter and Better Anti-Tuberculosis Regimens.

Riccardi N, Del Puente F, Magnè F, Taramasso L, Di Biagio A.

Recent Pat Antiinfect Drug Discov. 2018;13(1):3-11. doi: 10.2174/1574891X12666170619101904. Review.

PMID:
28625141
20.

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Taramasso L, Ricci E, Celesia BM, Bonfanti P, Quirino T, Squillace N, Nicolini LA, Maggi P, Martinelli C, De Socio GV, Di Biagio A; on behalf CISAI Study Group.

Clin Res Hepatol Gastroenterol. 2017 Oct;41(5):e76-e79. doi: 10.1016/j.clinre.2017.03.006. Epub 2017 Apr 21. No abstract available.

PMID:
28438572
21.

Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study.

Grignolo S, Agnello R, Gerbaldo D, Gotta C, Alicino C, Del Puente F, Taramasso L, Bruzzone B, Gustavino C, Trasino S, DE Maria A, Icardi G, Viscoli C, DI Biagio A.

Epidemiol Infect. 2017 Jun;145(8):1658-1669. doi: 10.1017/S095026881700053X. Epub 2017 Mar 22.

PMID:
28325171
22.

Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more?

Riccardi N, Nosenzo F, Peraldo F, Sarocchi F, Taramasso L, Traverso P, Viscoli C, Di Biagio A, Derchi LE, De Maria A.

PLoS Negl Trop Dis. 2017 Mar 16;11(3):e0005237. doi: 10.1371/journal.pntd.0005237. eCollection 2017 Mar. No abstract available.

23.

Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?

Di Biagio A, Ameri M, Sirello D, Cenderello G, Di Bella E, Taramasso L, Giannini B, Giacomini M, Viscoli C, Cassola G, Montefiori M.

BMC Infect Dis. 2017 Feb 6;17(1):127. doi: 10.1186/s12879-017-2199-x.

24.

Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.

De Socio GV, Ricci E, Maggi P, Parruti G, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Bonfanti P, Pucci G, Schillaci G; CISAI study group.

J Hypertens. 2017 Feb;35(2):409-416. doi: 10.1097/HJH.0000000000001150.

PMID:
28005710
25.

Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides.

Di Biagio A, Riccardi N, Taramasso L, Capetti A, Cenderello G, Signori A, Vitiello P, Guerra M, de Socio GV, Cassola G, Quirino T, Viscoli C.

Int J Antimicrob Agents. 2016 Nov;48(5):551-554. doi: 10.1016/j.ijantimicag.2016.07.009. Epub 2016 Aug 17.

PMID:
27566908
26.

Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency.

Cenderello G, Di Biagio A, Riccardi N, Taramasso L, De Maria A, Cassola G, Viscoli C.

New Microbiol. 2016 Oct;39(4):299-300. Epub 2016 Aug 23.

27.

Onychomadesis in a male patient with secondary syphilis.

Di Biagio A, Taramasso L, Gustinetti G, Riccardi N, Viscoli C.

Int J STD AIDS. 2016 Jul;27(8):704-5. doi: 10.1177/0956462416628703. No abstract available.

PMID:
27278451
28.

HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes.

Tatarelli P, Taramasso L, Di Biagio A, Sticchi L, Nigro N, Barresi R, Viscoli C, Bruzzone B.

New Microbiol. 2016 Apr;39(2):150-2.

29.

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio GV, Ricci E, Parruti G, Calza L, Maggi P, Celesia BM, Orofino G, Madeddu G, Martinelli C, Menzaghi B, Taramasso L, Penco G, Carenzi L, Franzetti M, Bonfanti P.

Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.

PMID:
27048184
30.

Bloodstream infections in HIV-infected patients.

Taramasso L, Tatarelli P, Di Biagio A.

Virulence. 2016 Apr 2;7(3):320-8. doi: 10.1080/21505594.2016.1158359. Review.

31.

Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection.

Cenderello G, Taramasso L, Riccardi N, Di Biagio A, Cassola G, De Maria A.

Clin Infect Dis. 2016 May 15;62(10):1323. doi: 10.1093/cid/ciw087. Epub 2016 Feb 16. No abstract available.

PMID:
26908811
32.

Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient.

Nicolini LA, Taramasso L, Ferrarazzo G, Fiz F, Sambuceti G, Viscoli C, Di Biagio A.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):868-9. doi: 10.1089/AID.2014.0372. Epub 2015 May 11. No abstract available.

PMID:
25870097
33.

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals.

Taramasso L, Madeddu G, Ricci E, De Socio GV, Menzaghi B, Orofino G, Passerini S, Franzetti M, Maggi P, Dentone C, Martinelli C, Celesia BM, Penco G, Libertone R, Quirino T, Bonfanti P, Di Biagio A; CISAI Study Group.

Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12.

PMID:
25661363
34.

Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports.

Taramasso L, Dentone C, Alessandrini A, Bruzzone B, Icardi G, Garraffo R, De Macina I, Viscoli C, Di Biagio A; HIV/HCV Collaborative Liguria Group.

Int J STD AIDS. 2015 Oct;26(11):831-4. doi: 10.1177/0956462414556330. Epub 2014 Oct 20.

PMID:
25332227
35.

Pineal germinoma in a child with interferon-γ receptor 1 deficiency. case report and literature review.

Taramasso L, Boisson-Dupuis S, Garrè ML, Bondi E, Cama A, Nozza P, Morana G, Casanova JL, Marazzi MG.

J Clin Immunol. 2014 Nov;34(8):922-7. doi: 10.1007/s10875-014-0098-0. Epub 2014 Sep 14. Review.

PMID:
25216720
36.

Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy?

Di Biagio A, Prinapori R, Taramasso L, Gustinetti G, Sticchi L, Bruzzone B, Viscoli C.

Recent Pat Antiinfect Drug Discov. 2014;9(1):41-51. Review.

PMID:
25030944
37.

Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.

Nicolini LA, Taramasso L, Schiavetti I, Giannini EG, Beltrame A, Feasi M, Cassola G, Grasso A, Bartolacci V, Sticchi L, Picciotto A, Viscoli C; Ligurian HBV Study Group.

Antivir Ther. 2015;20(2):193-7. doi: 10.3851/IMP2819. Epub 2014 Jun 25.

PMID:
24963642
38.

Therapeutic management of chronic hepatitis B in clinical practice: a region-wide survey.

Giannini EG, Marenco S, Boni S, Beltrame A, Nicolini LA, Taramasso L, Feasi M, Grasso A, De Leo P, Percario G, Bartolacci V, Artioli S, Viscoli C, Cassola G, Testa R, Anselmo M, Riccio G, Savarino V, Picciotto A; Ligurian Hepatitis B Virus Study Group.

J Clin Gastroenterol. 2015 Mar;49(3):228-34. doi: 10.1097/MCG.0000000000000106.

PMID:
24583753
39.

Pharmacokinetics of lopinavir determined with an ELISA test in youths with perinatally acquired HIV.

Prinapori R, Rosso R, Di Biagio A, Miletich F, Furfaro E, Taramasso L, Ginocchio F, Giacomet V, Nulvesu L, Sormani MP, Schiavetti I, Signori A, De Hoffer L, Viscoli C.

Indian J Pediatr. 2014 Sep;81(9):856-60. doi: 10.1007/s12098-013-1198-1. Epub 2013 Sep 7.

PMID:
24014186
40.

[Functional tricuspid regurgitation: the increasing clinical importance of the "forgotten valve"].

Taramasso M, Maisano F, Vanermen H, Nisi T, Gaudioso F, Buzzatti N, Pozzoli A, Taramasso L, La Canna G, Alfieri O.

Recenti Prog Med. 2012 Oct;103(10):351-8. doi: 10.1701/1171.12976. Italian.

PMID:
23114397
41.

Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.

Mikulska M, Taramasso L, Giacobbe DR, Caligiuri P, Bruzzone B, Di Biagio A, Viscoli C.

J Med Virol. 2012 Sep;84(9):1340-3. doi: 10.1002/jmv.23338.

PMID:
22825811
42.

Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.

Bassetti M, Taramasso L, Giacobbe DR, Pelosi P.

Expert Rev Anti Infect Ther. 2012 May;10(5):585-96. doi: 10.1586/eri.12.36. Review.

PMID:
22702322
43.

Will new antimicrobials overcome resistance among Gram-negatives?

Bassetti M, Ginocchio F, Mikulska M, Taramasso L, Giacobbe DR.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):909-22. doi: 10.1586/eri.11.107. Review.

PMID:
21973303
44.

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.

Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C.

PLoS One. 2011;6(9):e24198. doi: 10.1371/journal.pone.0024198. Epub 2011 Sep 15.

45.

Lamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.

Taramasso L, Caligiuri P, Di Biagio A, Bruzzone B, Rosso R, Icardi G, Viscoli C.

J Med Virol. 2011 Nov;83(11):1905-8. doi: 10.1002/jmv.22192.

PMID:
21915864
46.

Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen.

Rosso R, Di Biagio A, Maggiolo F, Nulvesu L, Callegaro AP, Taramasso L, Bruzzone B, Viscoli C.

AIDS Care. 2012;24(1):54-8. doi: 10.1080/09540121.2011.596511. Epub 2011 Jul 29.

PMID:
21800951

Supplemental Content

Loading ...
Support Center